ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 81 filers reported holding ALLOVIR INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $208,304 | +71.9% | 287,990 | +79.4% | 0.00% | – |
| Q1 2024 | $121,156 | -61.8% | 160,493 | -65.6% | 0.00% | – |
| Q4 2023 | $316,835 | -52.0% | 466,071 | +51.7% | 0.00% | – |
| Q3 2023 | $660,336 | -39.8% | 307,133 | -4.8% | 0.00% | – |
| Q2 2023 | $1,097,272 | +72.4% | 322,727 | +99.8% | 0.00% | – |
| Q1 2023 | $636,464 | -42.6% | 161,539 | -25.3% | 0.00% | – |
| Q4 2022 | $1,108,742 | +81007.7% | 216,129 | +24.7% | 0.00% | – |
| Q3 2022 | $1,367 | +53.3% | 173,331 | -24.2% | 0.00% | – |
| Q2 2022 | $892 | -99.9% | 228,667 | +111.5% | 0.00% | – |
| Q1 2022 | $730,000 | -39.1% | 108,104 | +16.7% | 0.00% | – |
| Q4 2021 | $1,199,000 | -53.8% | 92,609 | -10.6% | 0.00% | -100.0% |
| Q3 2021 | $2,597,000 | +66.9% | 103,643 | +31.5% | 0.00% | – |
| Q2 2021 | $1,556,000 | -76.3% | 78,841 | -71.9% | 0.00% | -100.0% |
| Q1 2021 | $6,559,000 | +463.5% | 280,310 | +826.0% | 0.00% | – |
| Q4 2020 | $1,164,000 | -32.2% | 30,271 | -51.5% | 0.00% | – |
| Q3 2020 | $1,716,000 | – | 62,404 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,323,371 | $15,683,000 | 0.66% |
| GMT CAPITAL CORP | 1,138,070 | $7,682,000 | 0.48% |
| RA Capital Management | 1,440,525 | $9,724,000 | 0.21% |
| Redmile Group, LLC | 823,371 | $5,558,000 | 0.17% |
| Samsara BioCapital, LLC | 82,336 | $556,000 | 0.14% |
| Woodline Partners LP | 1,087,093 | $7,338,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 93,166 | $629,000 | 0.08% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,532 | $7,719,000 | 0.04% |
| Virtus ETF Advisers LLC | 10,463 | $71,000 | 0.03% |
| PDT Partners, LLC | 30,198 | $204,000 | 0.02% |